Concepts (234)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Budgets | 1 | 2012 | 10 | 0.440 |
Why?
|
| Research Support as Topic | 1 | 2012 | 25 | 0.430 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2012 | 29 | 0.430 |
Why?
|
| Biomedical Research | 1 | 2012 | 154 | 0.380 |
Why?
|
| Cachexia | 1 | 2010 | 6 | 0.370 |
Why?
|
| Biological Factors | 1 | 2010 | 10 | 0.360 |
Why?
|
| Lipolysis | 1 | 2010 | 17 | 0.360 |
Why?
|
| Adipose Tissue | 1 | 2010 | 327 | 0.290 |
Why?
|
| DNA | 5 | 2012 | 204 | 0.290 |
Why?
|
| Pepsin A | 4 | 2007 | 8 | 0.280 |
Why?
|
| Membrane Glycoproteins | 1 | 2006 | 97 | 0.280 |
Why?
|
| Gastroesophageal Reflux | 4 | 2007 | 25 | 0.270 |
Why?
|
| Ovarian Neoplasms | 1 | 2006 | 87 | 0.270 |
Why?
|
| Light | 4 | 2011 | 25 | 0.220 |
Why?
|
| DNA, Catalytic | 3 | 2010 | 3 | 0.190 |
Why?
|
| Molecular Sequence Data | 6 | 2012 | 350 | 0.170 |
Why?
|
| Gene Expression Regulation | 2 | 2011 | 481 | 0.160 |
Why?
|
| Amino Acid Sequence | 5 | 2012 | 280 | 0.150 |
Why?
|
| Escherichia coli | 2 | 2007 | 82 | 0.140 |
Why?
|
| Serine Endopeptidases | 2 | 2006 | 19 | 0.140 |
Why?
|
| Nucleic Acid Conformation | 2 | 2012 | 46 | 0.130 |
Why?
|
| Transcription, Genetic | 2 | 2012 | 136 | 0.120 |
Why?
|
| Ultraviolet Rays | 3 | 2009 | 46 | 0.120 |
Why?
|
| Membrane Proteins | 2 | 2006 | 256 | 0.120 |
Why?
|
| Recombinant Proteins | 3 | 2012 | 248 | 0.120 |
Why?
|
| Culture Media, Conditioned | 2 | 2012 | 52 | 0.120 |
Why?
|
| Ubiquinone | 1 | 2013 | 8 | 0.110 |
Why?
|
| DNA Restriction Enzymes | 2 | 2009 | 5 | 0.110 |
Why?
|
| Benzodioxoles | 2 | 2009 | 6 | 0.110 |
Why?
|
| Fatigue | 1 | 2013 | 69 | 0.110 |
Why?
|
| Academies and Institutes | 1 | 2012 | 5 | 0.110 |
Why?
|
| Salaries and Fringe Benefits | 1 | 2012 | 10 | 0.110 |
Why?
|
| Vitamins | 1 | 2013 | 59 | 0.110 |
Why?
|
| Financing, Government | 1 | 2012 | 10 | 0.110 |
Why?
|
| Research Personnel | 1 | 2012 | 13 | 0.110 |
Why?
|
| Faculty | 1 | 2012 | 15 | 0.110 |
Why?
|
| Matrix Metalloproteinases | 1 | 2012 | 9 | 0.110 |
Why?
|
| Ephrin-A1 | 1 | 2012 | 11 | 0.110 |
Why?
|
| Models, Molecular | 3 | 2007 | 178 | 0.110 |
Why?
|
| Oligonucleotides | 1 | 2012 | 27 | 0.110 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2012 | 83 | 0.100 |
Why?
|
| Photic Stimulation | 1 | 2012 | 155 | 0.100 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2009 | 60 | 0.100 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 2011 | 17 | 0.100 |
Why?
|
| Bacterial Proteins | 2 | 2009 | 77 | 0.100 |
Why?
|
| Peroxidase | 2 | 2008 | 33 | 0.100 |
Why?
|
| Mice | 4 | 2010 | 2372 | 0.100 |
Why?
|
| NF-kappa B | 1 | 2011 | 75 | 0.100 |
Why?
|
| Polymerase Chain Reaction | 2 | 2009 | 172 | 0.100 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2012 | 249 | 0.100 |
Why?
|
| Oligodeoxyribonucleotides, Antisense | 1 | 2010 | 5 | 0.090 |
Why?
|
| Substrate Specificity | 5 | 2009 | 84 | 0.090 |
Why?
|
| Seminal Plasma Proteins | 1 | 2010 | 3 | 0.090 |
Why?
|
| 3T3-L1 Cells | 1 | 2010 | 11 | 0.090 |
Why?
|
| Palmitic Acid | 1 | 2010 | 11 | 0.090 |
Why?
|
| Serum | 1 | 2010 | 20 | 0.090 |
Why?
|
| Cell Size | 1 | 2010 | 32 | 0.090 |
Why?
|
| Animals | 7 | 2010 | 7302 | 0.090 |
Why?
|
| Time Factors | 3 | 2010 | 2003 | 0.090 |
Why?
|
| Tumor Burden | 1 | 2010 | 60 | 0.090 |
Why?
|
| Neoplasm Transplantation | 1 | 2010 | 76 | 0.090 |
Why?
|
| Tumor Cells, Cultured | 1 | 2010 | 158 | 0.090 |
Why?
|
| Rats, Inbred F344 | 1 | 2010 | 125 | 0.090 |
Why?
|
| Thymidine | 1 | 2009 | 7 | 0.090 |
Why?
|
| Alkenes | 1 | 2009 | 1 | 0.090 |
Why?
|
| Nitro Compounds | 1 | 2009 | 4 | 0.090 |
Why?
|
| Glutathione Transferase | 1 | 2009 | 18 | 0.090 |
Why?
|
| Sarcoma | 1 | 2010 | 56 | 0.090 |
Why?
|
| DNA-Directed DNA Polymerase | 1 | 2009 | 5 | 0.090 |
Why?
|
| Random Allocation | 1 | 2010 | 213 | 0.090 |
Why?
|
| Mutagenesis | 1 | 2009 | 32 | 0.090 |
Why?
|
| PPAR gamma | 1 | 2009 | 45 | 0.090 |
Why?
|
| Breast Neoplasms | 2 | 2013 | 667 | 0.090 |
Why?
|
| Plague Vaccine | 1 | 2008 | 1 | 0.090 |
Why?
|
| Pore Forming Cytotoxic Proteins | 1 | 2008 | 4 | 0.090 |
Why?
|
| Triglycerides | 1 | 2010 | 214 | 0.080 |
Why?
|
| Antigens, Bacterial | 1 | 2008 | 18 | 0.080 |
Why?
|
| Bass | 1 | 2008 | 1 | 0.080 |
Why?
|
| Vitellogenins | 1 | 2008 | 1 | 0.080 |
Why?
|
| Fishes | 1 | 2008 | 7 | 0.080 |
Why?
|
| Flagellin | 1 | 2008 | 19 | 0.080 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2008 | 30 | 0.080 |
Why?
|
| Gene Expression | 1 | 2010 | 332 | 0.080 |
Why?
|
| Gene Silencing | 1 | 2008 | 49 | 0.080 |
Why?
|
| Fatty Acids | 1 | 2009 | 93 | 0.080 |
Why?
|
| Mutation | 2 | 2012 | 466 | 0.080 |
Why?
|
| Base Sequence | 4 | 2010 | 240 | 0.080 |
Why?
|
| Deoxyguanosine | 1 | 2008 | 4 | 0.080 |
Why?
|
| Rats | 2 | 2010 | 1604 | 0.080 |
Why?
|
| Tryptases | 1 | 2008 | 1 | 0.080 |
Why?
|
| Pancreatic Elastase | 1 | 2008 | 3 | 0.080 |
Why?
|
| Kininogen, High-Molecular-Weight | 1 | 2008 | 6 | 0.080 |
Why?
|
| Antineoplastic Agents | 1 | 2013 | 546 | 0.080 |
Why?
|
| Body Composition | 1 | 2010 | 365 | 0.080 |
Why?
|
| Ferritins | 1 | 2008 | 46 | 0.080 |
Why?
|
| Hydroxymethylglutaryl-CoA Synthase | 1 | 2007 | 1 | 0.080 |
Why?
|
| Aldehydes | 1 | 2007 | 4 | 0.080 |
Why?
|
| Mitochondria, Liver | 1 | 2007 | 7 | 0.080 |
Why?
|
| Laryngeal Diseases | 1 | 2007 | 10 | 0.080 |
Why?
|
| Oxidoreductases | 1 | 2007 | 20 | 0.080 |
Why?
|
| Weight Loss | 1 | 2010 | 414 | 0.070 |
Why?
|
| Gastrointestinal Agents | 1 | 2006 | 6 | 0.070 |
Why?
|
| Larynx | 1 | 2006 | 19 | 0.070 |
Why?
|
| Neoplasms | 1 | 2012 | 612 | 0.070 |
Why?
|
| Heat-Shock Proteins | 1 | 2006 | 28 | 0.070 |
Why?
|
| Gastric Juice | 1 | 2005 | 1 | 0.070 |
Why?
|
| Laryngitis | 1 | 2005 | 2 | 0.070 |
Why?
|
| Carbonic Anhydrase III | 1 | 2004 | 1 | 0.060 |
Why?
|
| Esophagitis, Peptic | 1 | 2004 | 2 | 0.060 |
Why?
|
| Humans | 11 | 2013 | 29220 | 0.060 |
Why?
|
| Escherichia coli Proteins | 1 | 2004 | 31 | 0.060 |
Why?
|
| Mass Spectrometry | 3 | 2012 | 100 | 0.060 |
Why?
|
| Photochemistry | 3 | 2008 | 5 | 0.060 |
Why?
|
| United States | 1 | 2012 | 3648 | 0.060 |
Why?
|
| Cell Line, Tumor | 3 | 2012 | 681 | 0.060 |
Why?
|
| Protein Binding | 3 | 2008 | 199 | 0.060 |
Why?
|
| Female | 7 | 2013 | 18241 | 0.060 |
Why?
|
| Photochemical Processes | 2 | 2011 | 3 | 0.050 |
Why?
|
| Blotting, Western | 3 | 2007 | 281 | 0.050 |
Why?
|
| Transfection | 2 | 2012 | 192 | 0.050 |
Why?
|
| Peptides | 2 | 2012 | 118 | 0.040 |
Why?
|
| Enzyme Activation | 2 | 2010 | 126 | 0.040 |
Why?
|
| DNA Primers | 2 | 2009 | 87 | 0.040 |
Why?
|
| RNA | 2 | 2010 | 88 | 0.040 |
Why?
|
| Kinetics | 2 | 2009 | 205 | 0.040 |
Why?
|
| Molecular Structure | 2 | 2008 | 53 | 0.040 |
Why?
|
| Isoenzymes | 2 | 2009 | 63 | 0.040 |
Why?
|
| Protein Structure, Tertiary | 2 | 2007 | 95 | 0.040 |
Why?
|
| Binding Sites | 2 | 2008 | 125 | 0.040 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 2007 | 66 | 0.040 |
Why?
|
| HSP70 Heat-Shock Proteins | 2 | 2007 | 25 | 0.040 |
Why?
|
| Prospective Studies | 3 | 2007 | 2027 | 0.040 |
Why?
|
| Laryngeal Mucosa | 2 | 2007 | 3 | 0.040 |
Why?
|
| Isoleucine | 2 | 2006 | 8 | 0.030 |
Why?
|
| Gastric Acidity Determination | 2 | 2005 | 4 | 0.030 |
Why?
|
| Prognosis | 2 | 2013 | 1363 | 0.030 |
Why?
|
| Probability | 2 | 2005 | 150 | 0.030 |
Why?
|
| Sensitivity and Specificity | 2 | 2005 | 533 | 0.030 |
Why?
|
| Administration, Oral | 1 | 2013 | 169 | 0.030 |
Why?
|
| Phosphoinositide Phospholipase C | 1 | 2012 | 3 | 0.030 |
Why?
|
| Patient Participation | 1 | 2013 | 62 | 0.030 |
Why?
|
| Ligands | 1 | 2012 | 81 | 0.030 |
Why?
|
| Male | 5 | 2008 | 17876 | 0.030 |
Why?
|
| Methods | 1 | 2011 | 7 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2013 | 504 | 0.030 |
Why?
|
| Severity of Illness Index | 2 | 2005 | 864 | 0.030 |
Why?
|
| Adult | 3 | 2013 | 8468 | 0.030 |
Why?
|
| Alkaline Phosphatase | 1 | 2011 | 36 | 0.030 |
Why?
|
| Dietary Supplements | 1 | 2013 | 170 | 0.030 |
Why?
|
| Cell Movement | 1 | 2012 | 161 | 0.030 |
Why?
|
| Aged | 3 | 2013 | 9515 | 0.020 |
Why?
|
| Middle Aged | 3 | 2013 | 10872 | 0.020 |
Why?
|
| Deoxyribonuclease BamHI | 1 | 2009 | 1 | 0.020 |
Why?
|
| Deoxyribonuclease EcoRI | 1 | 2009 | 1 | 0.020 |
Why?
|
| Deoxyribonucleases, Type II Site-Specific | 1 | 2009 | 3 | 0.020 |
Why?
|
| DNA Cleavage | 1 | 2009 | 4 | 0.020 |
Why?
|
| Spectrophotometry, Ultraviolet | 1 | 2009 | 18 | 0.020 |
Why?
|
| Solubility | 1 | 2009 | 38 | 0.020 |
Why?
|
| Templates, Genetic | 1 | 2009 | 3 | 0.020 |
Why?
|
| Nucleosides | 1 | 2009 | 10 | 0.020 |
Why?
|
| Sequence Deletion | 1 | 2009 | 36 | 0.020 |
Why?
|
| Point Mutation | 1 | 2009 | 23 | 0.020 |
Why?
|
| Luciferases, Renilla | 1 | 2008 | 2 | 0.020 |
Why?
|
| Phosphorothioate Oligonucleotides | 1 | 2008 | 2 | 0.020 |
Why?
|
| Cloning, Molecular | 1 | 2009 | 74 | 0.020 |
Why?
|
| Yersinia pestis | 1 | 2008 | 1 | 0.020 |
Why?
|
| Toll-Like Receptor 5 | 1 | 2008 | 2 | 0.020 |
Why?
|
| Drug Storage | 1 | 2008 | 3 | 0.020 |
Why?
|
| Drug Stability | 1 | 2008 | 8 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 2008 | 37 | 0.020 |
Why?
|
| Cell Line | 1 | 2010 | 450 | 0.020 |
Why?
|
| NIH 3T3 Cells | 1 | 2008 | 43 | 0.020 |
Why?
|
| Virulence Factors | 1 | 2008 | 8 | 0.020 |
Why?
|
| Immunization, Secondary | 1 | 2008 | 9 | 0.020 |
Why?
|
| RNA 3' Polyadenylation Signals | 1 | 2008 | 1 | 0.020 |
Why?
|
| Sequence Homology | 1 | 2008 | 3 | 0.020 |
Why?
|
| von Willebrand Factor | 1 | 2008 | 17 | 0.020 |
Why?
|
| Antibodies, Bacterial | 1 | 2008 | 31 | 0.020 |
Why?
|
| Temperature | 1 | 2008 | 55 | 0.020 |
Why?
|
| Sequence Alignment | 1 | 2008 | 63 | 0.020 |
Why?
|
| Phylogeny | 1 | 2008 | 58 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2008 | 160 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2008 | 97 | 0.020 |
Why?
|
| Biocatalysis | 1 | 2008 | 19 | 0.020 |
Why?
|
| Succinimides | 1 | 2008 | 2 | 0.020 |
Why?
|
| Macrophages, Alveolar | 1 | 2008 | 9 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2008 | 32 | 0.020 |
Why?
|
| Organophosphorus Compounds | 1 | 2008 | 35 | 0.020 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 2007 | 11 | 0.020 |
Why?
|
| Zinc | 1 | 2008 | 32 | 0.020 |
Why?
|
| Methionine Sulfoxide Reductases | 1 | 2007 | 1 | 0.020 |
Why?
|
| Gastric Acid | 1 | 2007 | 2 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2013 | 2114 | 0.020 |
Why?
|
| Methionine | 1 | 2007 | 7 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2008 | 440 | 0.020 |
Why?
|
| Esophagoscopy | 1 | 2007 | 19 | 0.020 |
Why?
|
| Quality of Life | 1 | 2013 | 820 | 0.020 |
Why?
|
| Macaca fascicularis | 1 | 2008 | 389 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2007 | 139 | 0.020 |
Why?
|
| Oxidation-Reduction | 1 | 2008 | 250 | 0.020 |
Why?
|
| Phenylalanine | 1 | 2006 | 5 | 0.020 |
Why?
|
| Asparagine | 1 | 2006 | 6 | 0.020 |
Why?
|
| Gene Library | 1 | 2006 | 9 | 0.020 |
Why?
|
| Fluorescence Resonance Energy Transfer | 1 | 2006 | 8 | 0.020 |
Why?
|
| Peptide Library | 1 | 2006 | 6 | 0.020 |
Why?
|
| Computational Biology | 1 | 2007 | 86 | 0.020 |
Why?
|
| Models, Chemical | 1 | 2006 | 30 | 0.020 |
Why?
|
| Microscopy, Confocal | 1 | 2006 | 62 | 0.020 |
Why?
|
| Acid-Base Equilibrium | 1 | 2005 | 9 | 0.020 |
Why?
|
| Radioimmunoassay | 1 | 2005 | 21 | 0.020 |
Why?
|
| Swine | 1 | 2006 | 201 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2007 | 747 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2005 | 152 | 0.020 |
Why?
|
| Bacterial Outer Membrane Proteins | 1 | 2004 | 7 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2013 | 3728 | 0.020 |
Why?
|
| Ethanol | 1 | 2007 | 185 | 0.020 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2004 | 35 | 0.020 |
Why?
|
| Protein Precursors | 1 | 2004 | 22 | 0.020 |
Why?
|
| Sampling Studies | 1 | 2004 | 40 | 0.020 |
Why?
|
| Monitoring, Physiologic | 1 | 2005 | 68 | 0.020 |
Why?
|
| Protein Conformation | 1 | 2004 | 85 | 0.020 |
Why?
|
| Tissue Culture Techniques | 1 | 2004 | 40 | 0.020 |
Why?
|
| Amino Acids | 1 | 2004 | 41 | 0.020 |
Why?
|
| Alcohol Drinking | 1 | 2007 | 246 | 0.020 |
Why?
|
| Biopsy, Needle | 1 | 2004 | 89 | 0.020 |
Why?
|
| Inflammation | 1 | 2008 | 508 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2005 | 454 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2004 | 293 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2006 | 800 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2004 | 519 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2004 | 860 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2005 | 1695 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2004 | 1313 | 0.010 |
Why?
|
| Adolescent | 1 | 2006 | 3265 | 0.010 |
Why?
|